Patent · US Active

Mutant reverse transcriptase and methods of use

US9783791B2 · kind B2 · utility

36Cited by
1References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 10, 2006
Grant dateOct 10, 2017
Priority date
Expiry dateFeb 29, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC40B50/06
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.